Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy-Reference-Cited by-同舟云学术

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy

Published:2019-12-09 Issue:2 Volume:18 Page:136-139
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Stefanou Maria‐Ioanna¹²³,Gepfner‐Tuma Irina¹²³,Brendle Cornelia¹⁴,Kowarik Markus¹²³,Meiwes Andreas⁵⁶,Eigentler Thomas⁵⁶^ORCID,Müller Alisa⁵⁶,Garbe Claus⁵⁶,Ziemann Ulf¹²³,Tabatabai Ghazaleh¹²³,Forschner Andrea⁵⁶

Affiliation:

1. Center for CNS Tumors Comprehensive Cancer Center Tübingen‐Stuttgart Tübingen Germany

2. Department of Neurology & Stroke University Hospital Tübingen Tübingen Germany

3. Hertie‐Institute for Clinical Brain Research Eberhard‐Karls University of Tübingen Tübingen Germany

4. Department of Diagnostic and Interventional Neuroradiology University Hospital Tübingen Tübingen Germany

5. Center for Dermato‐Oncology Comprehensive Cancer Center Tübingen‐Stuttgart Tübingen Germany

6. Department of Dermatology University Hospital Tübingen Tübingen Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.13991

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuro-ophthalmic complications of modern anti-cancer drugs;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-12

2. Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors;Frontiers in Oncology;2023-12-19

3. Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention;Journal of Oncology;2022-01-18

4. Fatal encephalopathy with brainstem involvement under dabrafenib and trametinib in a BRAF-positive metastatic melanoma;Revue Neurologique;2021-11

5. Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size;Frontiers in Pediatrics;2021-07-01